Zoetis is a finished-dose manufacturer based in United States. It appears in 431 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with MPA (SE), DKMA (DK) and URPL (PL). Its GMP standing is certified by TMDA (TZ), NAFDAC (NG) and MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 19 August 2016 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Delémont, Switzerland | Not on file |
| Rockford Road Charles City, Nigeria | Not on file |
| Girona Spain, Nigeria | Not on file |
| INDEPENDENCE, United States | 3007919064 |
| Lincoln, United States | 1910179 |
| Kalamazoo, United States | 3010146372 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| MPA (SE) | 129 | None |
| DKMA (DK) | 107 | None |
| URPL (PL) | 82 | None |
| NPRA (MY) | 53 | None |
| TMDA (TZ) | 21 | 3 |
| ZAMRA (ZM) | 15 | None |
| NAFDAC (NG) | None | 3 |
| MHRA (UK) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2023 | $120.0B | Not reported | Not reported |
| 2022 | $100.0B | Not reported | Not reported |
| 2021 | $90.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Zoetis comes back tiered against every other supplier able to file there.
Start for free